FDA wants Biogen, Elan drug warning revised (Reuters)Reuters - Prescribing instructions for Biogen
Idec and Elan Corp's drug Tysabri should be revised to note
cases of a serious brain disorder in patients who were using it
as their sole treatment for multiple sclerosis, U.S. health
regulators said on Monday.
http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/reuters/biogen_elan_tysabri_dc.html